Steven L Gallion

Title: The Innovations of Steven L Gallion

Introduction

Steven L Gallion is an accomplished inventor based in Wallingford, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of certain substituted amides. His work has implications for treating diseases that respond to the inhibition of Btk activity and B-cell activity.

Latest Patents

Gallion holds a patent for "Certain substituted amides, method of making, and method of use thereof." This patent describes at least one chemical entity chosen from compounds of Formula 2 and pharmaceutically acceptable salts, solvates, chelates, non-covalent complexes, prodrugs, and mixtures thereof. The patent also details pharmaceutical compositions that comprise at least one chemical entity of the invention, along with at least one pharmaceutically acceptable vehicle chosen from carriers, adjuvants, and excipients. Furthermore, methods for treating patients suffering from certain diseases responsive to inhibition of Btk activity and/or B-cell activity are outlined, as well as methods for determining the presence of Btk in a sample.

Career Highlights

Throughout his career, Gallion has worked with notable companies such as Cgi Pharmaceuticals, Inc. and Gilead Connecticut, Inc. His experience in these organizations has allowed him to contribute to significant advancements in pharmaceutical research and development.

Collaborations

Some of his coworkers include David R Brittelli and Kevin S Currie. Their collaboration has likely fostered an environment of innovation and creativity in their respective projects.

Conclusion

Steven L Gallion's contributions to the field of pharmaceuticals through his patent and career experiences highlight his role as an influential inventor. His work continues to impact the treatment of diseases and the development of new pharmaceutical compositions.